Abstract
The novel coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), was announced as a pandemic in March 2020. Different diagnostic laboratory tests have been used to detect the infection. Each diagnostic tool, such as Chest Computed tomography (CT) imaging, genome sequencing, nucleic acid amplification methods, whole genome sequencing, microarray, and serology testing have several advantages and disadvantages. Nucleic acid amplification methods are better diagnostic tools for the detection of SARS-CoV-2 in early stages of the infection, while serological tests are more appropriate for the recognition of previously infected patients. In this review, we will briefly consider each diagnostic method, and discuss its pros and cons.
Keywords: COVID-19, SARS-CoV-2, Diagnosis, Polymerase chain reaction, Computed tomography, Serology.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:SARS-CoV-2: An Insight into Detection Tools
Volume: 21 Issue: 8
Author(s): Shaghayegh Khanmohammadi, Mohammadreza Tabary, Farnaz Araghi and Seyed Mohammad Tavangar*
Affiliation:
- Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran,Iran
Keywords: COVID-19, SARS-CoV-2, Diagnosis, Polymerase chain reaction, Computed tomography, Serology.
Abstract: The novel coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), was announced as a pandemic in March 2020. Different diagnostic laboratory tests have been used to detect the infection. Each diagnostic tool, such as Chest Computed tomography (CT) imaging, genome sequencing, nucleic acid amplification methods, whole genome sequencing, microarray, and serology testing have several advantages and disadvantages. Nucleic acid amplification methods are better diagnostic tools for the detection of SARS-CoV-2 in early stages of the infection, while serological tests are more appropriate for the recognition of previously infected patients. In this review, we will briefly consider each diagnostic method, and discuss its pros and cons.
Export Options
About this article
Cite this article as:
Khanmohammadi Shaghayegh , Tabary Mohammadreza, Araghi Farnaz and Tavangar Mohammad Seyed *, SARS-CoV-2: An Insight into Detection Tools, Infectious Disorders - Drug Targets 2021; 21 (8) : e160921189885 . https://dx.doi.org/10.2174/1871526520666210104151849
DOI https://dx.doi.org/10.2174/1871526520666210104151849 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epidemiological Characteristics of 64 Covid-19 Patients in Errachidia Province (Darâa-Tafilalet region), Morocco: A Retrospective Analysis
Reviews on Recent Clinical Trials Asymmetric Organocatalyzed Warfarin Synthesis in Aqueous and Nonaqueous Media: A Discussion in the Era of COVID-19 Pandemic
Current Organocatalysis COVID-19 and Alcohol Misuse: A Case Report
Infectious Disorders - Drug Targets In-silico Study to Identify Dietary Molecules as Potential SARS-CoV-2 Agents
Letters in Drug Design & Discovery Management of Idiopathic Intracranial Hypertension During the COVID-19 Pandemic
Reviews on Recent Clinical Trials Psychological Impact of Coronavirus (COVID-19) Disease on Cancer Patients
Coronaviruses B Cells: Programmers of CD4 T Cell Responses
Infectious Disorders - Drug Targets Prevention and Management of SARS-CoV-2 Infection Among the Health Care Workers
Coronaviruses Insights into Novel Coronavirus Disease 2019 (COVID-19): Current Understanding, Research, and Therapeutic Updates
Recent Patents on Biotechnology Subject Index To Volume 12
Current Pharmaceutical Design SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
Current Medicinal Chemistry Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus
Letters in Drug Design & Discovery The pH-Triggered Conversion of the PrP<sup>c</sup> to PrP<sup>sc</sup>
Current Topics in Medicinal Chemistry Microwave Assisted Synthesis, Characterization of Some New Isatin and Thiophene Derivatives as Cytotoxic and Chemopreventive Agents
Letters in Drug Design & Discovery Impact of Headache Frequency and Sleep on Migraine Patients During the COVID-19 Pandemic
Current Neurovascular Research Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19
Current Medicinal Chemistry Most Promising Compounds for Treating COVID-19 and Recent Trends in Antimicrobial & Antifungal Agents
Current Topics in Medicinal Chemistry Efficacy of Dexamethasone for the Treatment of COVID-19 Infection: A Perspective Review
Current Drug Delivery Chemodiversity in Freshwater and Terrestrial Cyanobacteria – A Source for Drug Discovery
Current Drug Targets Prediction of Infection and Death Ratio of COVID-19 Virus in Turkey by Using Artificial Neural Network (ANN)
Coronaviruses